200 related articles for article (PubMed ID: 23335975)
21. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
22. Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma.
Saad MA; Kuo SZ; Rahimy E; Zou AE; Korrapati A; Rahimy M; Kim E; Zheng H; Yu MA; Wang-Rodriguez J; Ongkeko WM
Mol Cancer; 2015 Oct; 14():181. PubMed ID: 26472042
[TBL] [Abstract][Full Text] [Related]
23. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
[TBL] [Abstract][Full Text] [Related]
24. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
Nohata N; Sone Y; Hanazawa T; Fuse M; Kikkawa N; Yoshino H; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Shozu M; Okamoto Y; Seki N
Oncotarget; 2011; 2(1-2):29-42. PubMed ID: 21378409
[TBL] [Abstract][Full Text] [Related]
25. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.
She K; Yan H; Huang J; Zhou H; He J
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29131440
[TBL] [Abstract][Full Text] [Related]
26. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187
[TBL] [Abstract][Full Text] [Related]
27. Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21.
Wu H; Pang P; Liu MD; Wang S; Jin S; Liu FY; Sun CF
Oncol Rep; 2018 Aug; 40(2):1138-1146. PubMed ID: 29901115
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
29. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
30. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.
Jing P; Sa N; Liu X; Liu X; Xu W
Exp Mol Pathol; 2016 Feb; 100(1):132-8. PubMed ID: 26704053
[TBL] [Abstract][Full Text] [Related]
31. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Liu MD; Wu H; Wang S; Pang P; Jin S; Sun CF; Liu FY
Gene; 2018 Mar; 646():1-7. PubMed ID: 29278769
[TBL] [Abstract][Full Text] [Related]
32. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
33. Identification of
Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
[TBL] [Abstract][Full Text] [Related]
34. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma.
Li J; Chen W; Luo L; Liao L; Deng X; Wang Y
Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
[TBL] [Abstract][Full Text] [Related]
36. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Fujimura L; Yoshino H; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2011 Jan; 38(1):209-17. PubMed ID: 21109942
[TBL] [Abstract][Full Text] [Related]
37. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
Qiu K; Huang Z; Huang Z; He Z; You S
Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
[TBL] [Abstract][Full Text] [Related]
38. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
39. A Feed-Forward Regulatory Loop between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis.
Xu CZ; Jiang C; Wu Q; Liu L; Yan X; Shi R
Cell Physiol Biochem; 2016; 40(5):1039-1051. PubMed ID: 27941336
[TBL] [Abstract][Full Text] [Related]
40. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]